Identification of a novel spinal dorsal horn astroglial d-amino acid oxidase-hydrogen peroxide pathway involved in morphine antinociceptive tolerance

Anesthesiology

Volumn 120, Issue 4, 2014, Pages 962-975

  Gong, Nian ^a   Li, Xin Yan ^a   Xiao, Qi ^a   Wang, Yong Xiang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOIC ACID; DEXTRO AMINO ACID OXIDASE; FORMALDEHYDE; HYDROGEN PEROXIDE; MORPHINE; OXIDOREDUCTASE INHIBITOR; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; NARCOTIC ANALGESIC AGENT;

ADULT; ANIMAL EXPERIMENT; ARTICLE; ASTROCYTE; CATALYST; CONTROLLED STUDY; GENE SILENCING; HOT PLATE TEST; MALE; MORPHINE TOLERANCE; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SAMPLE SIZE; SPINAL CORD DORSAL HORN; TAIL FLICK TEST; UPREGULATION; ANIMAL; DRUG TOLERANCE; ENZYMOLOGY; METABOLISM; PAIN; PHYSIOLOGY; SPINAL CORD; WISTAR RAT;

ANALGESICS, OPIOID; ANIMALS; ASTROCYTES; D-AMINO-ACID OXIDASE; DRUG TOLERANCE; HYDROGEN PEROXIDE; MALE; MICE; MORPHINE; PAIN; RATS; RATS, WISTAR; SPINAL CORD;

EID: 84900500903     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3182a66d2a     Document Type: Article

References (55)

1. Raghavendra V, Rutkowski MD, DeLeo JA: The role of spinal neuroimmune activation in morphine tolerance/hyperalgesia in neuropathic and sham-operated rats. J Neurosci 2002; 22:9980-9.
2. Johnston IN, Milligan ED, Wieseler-Frank J, Frank MG, Zapata V, Campisi J, Langer S, Martin D, Green P, Fleshner M, Leinwand L, Maier SF, Watkins LR: A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine. J Neurosci 2004; 24:7353-65.
3. Song P, Zhao ZQ: The involvement of glial cells in the development of morphine tolerance. Neurosci Res 2001; 39:281-6.
4. Watkins LR, Hutchinson MR, Johnston IN, Maier SF: Glia: Novel counter-regulators of opioid analgesia. Trends Neurosci 2005; 28:661-9.
5. Mayer DJ, Mao J, Holt J, Price DD: Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions. Proc Natl Acad Sci U S A 1999; 96:7731-6.
6. Batiniæ-Haberle I, Ndengele MM, Cuzzocrea S, Rebouças JS, Spasojeviæ I, Salvemini D: Lipophilicity is a critical parameter that dominates the efficacy of metalloporphyrins in blocking the development of morphine antinociceptive tolerance through peroxynitrite-mediated pathways. Free Radic Biol Med 2009; 46:212-9.
7. Bryant L, Doyle T, Chen Z, Cuzzocrea S, Masini E, Vinci MC, Esposito E, Mazzon E, Petrusca DN, Petrache I, Salvemini D: Spinal ceramide and neuronal apoptosis in morphine antinociceptive tolerance. Neurosci Lett 2009; 463:49-53.
8. Doyle T, Bryant L, Muscoli C, Cuzzocrea S, Esposito E, Chen Z, Salvemini D: Spinal NADPH oxidase is a source of superoxide in the development of morphine-induced hyperalgesia and antinociceptive tolerance. Neurosci Lett 2010; 483:85-9.
9. Muscoli C, Cuzzocrea S, Ndengele MM, Mollace V, Porreca F, Fabrizi F, Esposito E, Masini E, Matuschak GM, Salvemini D: Therapeutic manipulation of peroxynitrite attenuates the development of opiate-induced antinociceptive tolerance in mice. J Clin Invest 2007; 117:3530-9.
10. Ndengele MM, Cuzzocrea S, Masini E, Vinci MC, Esposito E, Muscoli C, Petrusca DN, Mollace V, Mazzon E, Li D, Petrache I, Matuschak GM, Salvemini D: Spinal ceramide modulates the development of morphine antinociceptive tolerance via peroxynitrite-mediated nitroxidative stress and neuroimmune activation. J Pharmacol Exp Ther 2009; 329:64-75.
11. Salvemini D, Neumann WL: Peroxynitrite: A strategic linchpin of opioid analgesic tolerance. Trends Pharmacol Sci 2009; 30:194-202.
12. Angermüller S, Islinger M, Völkl A: Peroxisomes and reactive oxygen species, a lasting challenge. Histochem Cell Biol 2009; 131:459-63.
13. Horiike K, Ishida T, Tanaka H, Arai R: Distribution of damino- Acid oxidase and d-serine in vertebrate brains. J Mol Catal B-Enzym 2001; 12:37-41.
14. Horiike K, Tojo H, Arai R, Nozaki M, Maeda T: D-amino-acid oxidase is confined to the lower brain stem and cerebellum in rat brain: Regional differentiation of astrocytes. Brain Res 1994; 652:297-303.
15. Horiike K, Tojo H, Arai R, Yamano T, Nozaki M, Maeda T: Localization of d-amino acid oxidase in Bergmann glial cells and astrocytes of rat cerebellum. Brain Res Bull 1987; 19:587-96.
16. Kappor R, Kapoor V: Distribution of d-amino acid oxidase (DAO) activity in the medulla and thoracic spinal cord of the rat: Implications for a role for D-serine in autonomic function. Brain Res 1997; 771:351-5.
17. Mitchell J, Paul P, Chen HJ, Morris A, Payling M, Falchi M, Habgood J, Panoutsou S, Winkler S, Tisato V, Hajitou A, Smith B, Vance C, Shaw C, Mazarakis ND, de-Belleroche J: Familial amyotrophic lateral sclerosis is associated with a mutation in d-amino acid oxidase. Proc Natl Acad Sci U S A 2010; 107:7556-61.
18. Verrall L, Walker M, Rawlings N, Benzel I, Kew JN, Harrison PJ, Burnet PW: d-Amino acid oxidase and serine racemase in human brain: Normal distribution and altered expression in schizophrenia. Eur J Neurosci 2007; 26:1657-69.
19. Wang YX, Gong N, Xin YF, Hao B, Zhou XJ, Pang CC: Biological implications of oxidation and unidirectional chiral inversion of d-amino acids. Curr Drug Metab 2012; 13:321-31.
20. Gong N, Gao ZY, Wang YC, Li XY, Huang JL, Hashimoto K, Wang YX: A series of d-amino acid oxidase inhibitors specifically prevents and reverses formalin-induced tonic pain in rats. J Pharmacol Exp Ther 2011; 336:282-93.
21. Hopkins SC, Zhao FY, Bowen CA, Fang X, Wei H, Heffernan ML, Spear KL, Spanswick DC, Varney MA, Large TH: Pharmacodynamic effects of a d-amino acid oxidase inhibitor indicate a spinal site of action in rat models of neuropathic pain. J Pharmacol Exp Ther 2013; 345:502-11.
22. Smith SM, Uslaner JM, Yao L, Mullins CM, Surles NO, Huszar SL, McNaughton CH, Pascarella DM, Kandebo M, Hinchliffe RM, Sparey T, Brandon NJ, Jones B, Venkatraman S, Young MB, Sachs N, Jacobson MA, Hutson PH: The behavioral and neurochemical effects of a novel d-amino acid oxidase inhibitor compound 8 [4H-thieno [3, 2-b]pyrrole-5-carboxylic acid] and D-serine. J Pharmacol Exp Ther 2009; 328:921-30.
23. Verrall L, Burnet PW, Betts JF, Harrison PJ: The neurobiology of d-amino acid oxidase and its involvement in schizophrenia. Mol Psychiatry 2010; 15:122-37.
24. Williams M: Genome-based CNS drug discovery: d-Amino acid oxidase (DAAO) as a novel target for antipsychotic medications: Progress and challenges. Biochem Pharmacol 2009; 78:1360-5.
25. Burnet PW, Anderson PN, Chen L, Nikiforova N, Harrison PJ, Wood MJ: d-amino acid oxidase knockdown in the mouse cerebellum reduces NR2A mRNA. Mol Cell Neurosci 2011; 46:167-75.
26. Chen XL, Li XY, Qian SB, Wang YC, Zhang PZ, Zhou XJ, Wang YX: Down-regulation of spinal d-amino acid oxidase expression blocks formalin-induced tonic pain. Biochem Biophys Res Commun 2012; 421:501-7.
27. Huang JL, Chen XL, Guo C, Wang YX: Contributions of spinal d-amino acid oxidase to bone cancer pain. Amino Acids 2012; 43:1905-18.
28. Lu JM, Gong N, Wang YC, Wang YX: d-Amino acid oxidasemediated increase in spinal hydrogen peroxide is mainly responsible for formalin-induced tonic pain. Br J Pharmacol 2012; 165:1941-55.
29. Hensley K, Pye QN, Maidt ML, Stewart CA, Robinson KA, Jaffrey F, Floyd RA: Interaction of alpha-phenyl-N-tert-butyl nitrone and alternative electron acceptors with complex I indicates a substrate reduction site upstream from the rotenone binding site. J Neurochem 1998; 71:2549-57.
30. Hassan WN, Cantuti-Castelevetri I, Denisova NA, Yee AS, Joseph JA, Paulson KE: The nitrone spin trap PBN alters the cellular response to H(2)O(2): Activation of the EGF receptor/ERK pathway. Free Radic Biol Med 2002; 32:551-61.
31. Chelikani P, Fita I, Loewen PC: Diversity of structures and properties among catalases. Cell Mol Life Sci 2004; 61:192-208.
32. Gong N, Wang YC, Wang HL, Ma AN, Hashimoto K, Wang YX: Interactions of the potent d-amino acid oxidase inhibitor CBIO with morphine in pain and tolerance to analgesia. Neuropharmacology 2012; 63:460-8.
33. Wong CS, Hsu MM, Chou R, Chou YY, Tung CS: Intrathecal cyclooxygenase inhibitor administration attenuates morphine antinociceptive tolerance in rats. Br J Anaesth 2000; 85:747-51.
34. Wang YX, Gao D, Pettus M, Phillips C, Bowersox SS: Interactions of intrathecally administered ziconotide, a selective blocker of neuronal N-type voltage-sensitive calcium channels, with morphine on nociception in rats. Pain 2000; 84:271-81.
35. Zhao W, Konno R, Zhou XJ, Yin M, Wang YX: Inhibition of D-amino-Acid oxidase activity induces pain relief in mice. Cell Mol Neurobiol 2008; 28:581-91.
36. Mansouri A, Muller FL, Liu Y, Ng R, Faulkner J, Hamilton M, Richardson A, Huang TT, Epstein CJ, Van-Remmen H: Alterations in mitochondrial function, hydrogen peroxide release and oxidative damage in mouse hind-limb skeletal muscle during aging. Mech Ageing Dev 2006; 127:298-306.
37. Vahl TP, Tauchi M, Durler TS, Elfers EE, Fernandes TM, Bitner RD, Ellis KS, Woods SC, Seeley RJ, Herman JP, D'Alessio DA: Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats. Endocrinology 2007; 148:4965-73.
38. Gong N, Ma AN, Zhang LJ, Luo XS, Zhang YH, Xu M, Wang YX: Site-specific PEGylation of exenatide analogues markedly improved their glucoregulatory activity. Br J Pharmacol 2011; 163:399-412.
39. Wang YX, Pang CC: Functional integrity of the central and sympathetic nervous systems is a prerequisite for pressor and tachycardic effects of diphenyleneiodonium, a novel inhibitor of nitric oxide synthase. J Pharmacol Exp Ther 1993; 265:263-72.
40. Gaetani GF, Ferraris AM, Rolfo M, Mangerini R, Arena S, Kirkman HN: Predominant role of catalase in the disposal of hydrogen peroxide within human erythrocytes. Blood 1996; 87:1595-9.
41. Lee I, Kim HK, Kim JH, Chung K, Chung JM: The role of reactive oxygen species in capsaicin-induced mechanical hyperalgesia and in the activities of dorsal horn neurons. Pain 2007; 133:9-17.
42. Lin HH, Chen CH, Hsieh WK, Chiu TH, Lai CC: Hydrogen peroxide increases the activity of rat sympathetic preganglionic neurons in vivo and in vitro. Neuroscience 2003; 121:641-7.
43. Sasabe J, Miyoshi Y, Suzuki M, Mita M, Konno R, Matsuoka M, Hamase K, Aiso S: d-amino acid oxidase controls motoneuron degeneration through D-serine. Proc Natl Acad Sci U S A 2012; 109:627-32.
44. Huang YN, Tsai RY, Lin SL, Chien CC, Cherng CH, Wu CT, Yeh CC, Wong CS: Amitriptyline attenuates astrocyte activation and morphine tolerance in rats: Role of the PSD-95/NR1/nNOS/PKCγ signaling pathway. Behav Brain Res 2012; 229:401-11.
45. Mattioli TA, Milne B, Cahill CM: Ultra-low dose naltrexone attenuates chronic morphine-induced gliosis in rats. Mol Pain 2010; 6:22.
46. Pollegioni L, Piubelli L, Sacchi S, Pilone MS, Molla G: Physiological functions of d-amino acid oxidases: From yeast to humans. Cell Mol Life Sci 2007; 64:1373-94.
47. Zhao WJ, Gao ZY, Wei H, Nie HZ, Zhao Q, Zhou XJ, Wang YX: Spinal D-amino acid oxidase contributes to neuropathic pain in rats. J Pharmacol Exp Ther 2010; 332:248-54.
48. Trujillo KA, Akil H: Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 1991; 251:85-7.
49. Mao J, Price DD, Mayer DJ: Experimental mononeuropathy reduces the antinociceptive effects of morphine: Implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain. Pain 1995; 61: 353-64.
50. Shu H, Hayashida M, Huang W, An K, Chiba S, Hanaoka K, Arita H: The comparison of effects of processed Aconiti tuber, U50488H and MK-801 on the antinociceptive tolerance to morphine. J Ethnopharmacol 2008; 117:158-65.
51. Mothet JP, Parent AT, Wolosker H, Brady RO Jr, Linden DJ, Ferris CD, Rogawski MA, Snyder SH: D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor. Proc Natl Acad Sci U S A 2000; 97:4926-31.
52. Panatier A, Theodosis DT, Mothet JP, Touquet B, Pollegioni L, Poulain DA, Oliet SH: Glia-derived D-serine controls NMDA receptor activity and synaptic memory. Cell 2006; 125:775-84.
53. Schell MJ, Molliver ME, Snyder SH: D-serine, an endogenous synaptic modulator: Localization to astrocytes and glutamate-stimulated release. Proc Natl Acad Sci U S A 1995; 92:3948-52.
54. Ruscheweyh R, Sandkühler J: Opioids and central sensitisation: II. Induction and reversal of hyperalgesia. Eur J Pain 2005; 9:149-52.
55. Mao J, Price DD, Mayer DJ: Mechanisms of hyperalgesia and morphine tolerance: A current view of their possible interactions. Pain 1995; 62:259-74.